Therapeutic Dendritic Cell Vaccination of Patients with Renal Cell Carcinoma

Induction of Interleukin 10–Producing, Nonproliferating Cd4+ T Cells with Regulatory Properties by Repetitive Stimulation with Allogeneic Immature Human Dendritic Cells

2000 • 1,577 citations

Antigen-Specific Inhibition of Effector T Cell Function in Humans after Injection of Immature Dendritic Cells

2001 • 1,384 citations

Dendritic cells as therapeutic vaccines against cancer

2005 • 1,195 citations

Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells

2005 • 998 citations

Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine.

2001 • 828 citations

The Linkage of Innate to Adaptive Immunity via Maturing Dendritic Cells In Vivo Requires CD40 Ligation in Addition to Antigen Presentation and CD80/86 Costimulation

2004 • 587 citations

Cancer regression in patients with metastatic melanoma after the transfer of autologous antitumor lymphocytes

2004 • 368 citations

Immunological and clinical responses in metastatic renal cancer patients vaccinated with tumor RNA-transfected dendritic cells.

2003 • 362 citations

B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells.

1994 • 347 citations

Manipulating dendritic cell biology for the active immunotherapy of cancer

2004 • 346 citations

Dendritic cells can present antigen in vivo in a tolerogenic or immunogenic fashion.

1996 • 330 citations

The First 1000 Dendritic Cell Vaccinees

2003 • 277 citations

RENAL CELL CARCINOMA: MANAGEMENT OF ADVANCED DISEASE

1999 • 272 citations

CELLULAR AND HUMORAL IMMUNE RESPONSES IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA AFTER VACCINATION WITH ANTIGEN PULSED DENDRITIC CELLS

1999 • 245 citations

Fusion Cell Vaccination of Patients with Metastatic Breast and Renal Cancer Induces Immunological and Clinical Responses

2004 • 239 citations

Immunotherapy of metastatic renal cell carcinoma with tumor lysate-pulsed autologous dendritic cells.

2002 • 230 citations

Histologic Predictors of Renal Cell Carcinoma Response to Interleukin-2-Based Therapy

2005 • 223 citations

CD4+CD25+ T Regulatory Cells, Immunotherapy of Cancer, and Interleukin-2

2005 • 214 citations

Dendritic-cell-based therapeutic vaccination against cancer

2005 • 203 citations

Regulatory T Cells in Immunologic Self-Tolerance and Autoimmune Disease

2005 • 198 citations

Part I: Vaccines for solid tumours

2004 • 197 citations

Intranodal Administration of Peptide-Pulsed Mature Dendritic Cell Vaccines Results in Superior CD8⁺T-Cell Function in Melanoma Patients

2003 • 169 citations

Unexplained Spontaneous Regression and Alpha‐interferon as Treatment for Metastatic Renal Carcinoma

1989 • 167 citations

Allogeneic Dendritic Cells Fused with Tumor Cells: Preclinical Results and Outcome of a Clinical Phase I/II Trial in Patients with Metastatic Renal Cell Carcinoma

2003 • 146 citations

Allogeneic dendritic cell vaccination against metastatic renal cell carcinoma with or without cyclophosphamide

2004 • 133 citations

Potentiation of human cell-mediated and humoral immunity by low-dose cyclophosphamide.

1984 • 124 citations

Dendritic cell?tumor cell hybrid vaccination for metastatic cancer

2004 • 122 citations

Distinct in vivo expression patterns of survivin splice variants in renal cell carcinomas

2002 • 121 citations

Role of Dendritic Cell Phenotype, Determinant Spreading, and Negative Costimulatory Blockade in Dendritic Cell-Based Melanoma Immunotherapy

2004 • 119 citations

Dendritic cell immunotherapy for urological cancers using cryopreserved allogeneic tumour lysate‐pulsed cells: a phase I/II study

2004 • 109 citations

Therapeutic vaccination against metastatic renal cell carcinoma by autologous dendritic cells: preclinical results and outcome of a first clinical phase I/II trial

2002 • 102 citations

Vaccination of Patients With Metastatic Renal Cell Carcinoma With Autologous Dendritic Cells Pulsed With Autologous Tumor Antigens in Combination With Interleukin-2: A Phase 1 Study

2002 • 98 citations

A Pilot Trial of Tumor Lysate-Loaded Dendritic Cells for the Treatment of Metastatic Renal Cell Carcinoma

2003 • 91 citations

Maturation of function in dendritic cells for tolerance and immunity

2005 • 91 citations

Modulating T-cell immunity to tumours: new strategies for monitoring T-cell responses

2002 • 68 citations

VEGF-Targeted Therapy in Metastatic Renal Cell Carcinoma

2005 • 65 citations

Renal-cell carcinoma: tumour markers, T-cell epitopes, and potential for new therapies

2003 • 62 citations

Therapeutic vaccination in patients with gastrointestinal malignancies. A review of immunological and clinical results

2005 • 61 citations

The biological treatment of renal-cell carcinoma and melanoma

2002 • 56 citations

Regimens With or Without Interferon-α as Treatment for Metastatic Melanoma and Renal Cell Carcinoma: An Overview of Randomized Trials

1999 • 55 citations

Differential Expression of Full-length Telomerase Reverse Transcriptase mRNA and Telomerase Activity between Normal and Malignant Renal Tissues

2005 • 55 citations

Therapy targeted at vascular endothelial growth factor in metastatic renal cell carcinoma: biology, clinical results and future development

2005 • 51 citations

Dendritic cells in vaccination therapies of human malignant disease*1

2004 • 42 citations

Clinical application of dendritic cells in cancer vaccination therapy

2003 • 42 citations

Secondary leukemia after first-line high-dose chemotherapy for patients with advanced germ cell cancer

2004 • 41 citations

Autoimmune Toxicities Associated with the Administration of Antitumor Vaccines and Low-Dose Interleukin-2

2005 • 41 citations

Tumor regression in patients with metastatic renal cancer treated with a monoclonal antibody to CTLA4 (MDX-010)

2005 • 38 citations

Immune Response Induced in Vitro by CD16^-and CD16⁺Monocyte-Derived Dendritic Cells in Patients with Metastatic Renal Cell Carcinoma Treated with Dendritic Cell Vaccines

2004 • 35 citations

Safety and efficacy of subcutaneous and continuous intravenous infusion rIL-2 in patients with metastatic renal cell carcinoma

2004 • 34 citations

Infiltration of Activated Dendritic Cells and T Cells in Renal Cell Carcinoma Following Combined Cytokine Immunotherapy

2005 • 32 citations

Dendritic cell immunotherapy for patients with metastatic renal cell carcinoma: University of Tokyo experience

2002 • 29 citations

Retraction Note to: Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids

2003 • 17 citations

Cited By (0)

No citing papers found in database